 |
|
 |
|
|
|
|
|
Home : Advanced Search : Course view :
|
 
| Course: |
The Role of High-field Strength MRI in the Diagnosis, Treatment, and Pathophysiology of MS |
| Target Audience: |
The intended audiences for the program are neurologists and radiologists who treat patients with MS.
Program Overview:
MRI techniques developed over the last two decades differ in their utility to predict clinical status in multiple sclerosis (MS). Gd-enhancing T1 and T2 lesions have limited value due to poor sensitivity and specificity for underlying pathophysiologic process. The use of high-field imaging protocols may increase sensitivity in detecting lesions and help identify pathology invisible on 1.5 T protocols. The pathology visualized with these new protocols is an important goal of MRI research. It is important for physicians and healthcare professionals who treat MS patients to be aware of new MRI protocols and research and the relevance to MS patient care. |
| Sponsor: |
This program has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for CME (ACCME) through joint sponsorship with the University at Buffalo School of Medicine and Biomedical Sciences and the Jacobs Neurological Institute.
|
| Accreditation: |
| The University at Buffalo of Medical & Biomedical Sciences is accredited by the Accreditation Council for Continuing Medical Education to offer continuing medical education for physicians. |
| Credit Designation: |
| The UB School of Medicine & Biomedical Sciences designates this educational activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| Faculty Listing: |
Robert Zivadinov, MD, PhD
Associate Professor, Neurology
University at Buffalo, Buffalo, NY
Director, BNAC
Buffalo, NY
Matilde Inglese, MD
Associate Professor, Dept. of Radiology and Neurology
New York University
New York City, NY, USA
Daniel Pelletier, MD
Associate Professor, Dept. of Neurology
University of California
San Francisco, CA, USA
|
| Subjects: |
- The Role of High-field Strength MRI in the Diagnosis, Treatment, and Pathophysiology of MS
|
| Objectives: |
- Discuss the use of high-field strength MRI in the diagnosis of patients with MS.
- Explain the role of high-field strength MRI in the treatment of MS patients.
- Compare the findings 1.5 and 3T protocols with respect MS pathophysiology and immunomodulatory treatments.
|
| Financial Disclosure: |
Contributors have been asked to disclose any relationship(s) they may have with any commercial supporter of the CME activity or with companies providing drugs, medical equipment, etc., that may have relevance to the content of their presentations or discussion. This disclosure is intended to provide participants with sufficient information to evaluate whether any given presentation has been influenced by the faculty's relationship(s) or financial interests with said companies.
Robert Zivadinov, MD, PhD
Honoraria: Teva Neuroscience and Biogen Idec
Consultancies: Teva Neuroscience and Biogen Idec
Research Grants: Teva Neuroscience, Biogen Idec, Genzyme, Bracco, Aspreva, Serono, Greatbatch, Questcor
Matilde Inglese, MD
Honoraria: Teva Neuroscience and Biogen Idec
Consultancies: Teva Neuroscience and Biogen Idec
Research Grants: Teva Neuroscience
Daniel Pelletier, MD
Honoraria: Teva Neuroscience, Bayer, Biogen Idec and Genentech
Consultancies: Synare Inc
Research Grants: Biogen Idec
Institutional Disclosure Statement
The Jacobs Neurological Institute has received donations to support its work from: Biogen Idec, Teva Neuroscience, Pfizer, Berlex, Athena Diagnostics.
The institute has received support for research, clinical trials and/or drug studies from: Biogen Idec, Teva Neuroscience, National MS Society.
|
- You are not currently logged in.
- To view content articles and complete the post-test for this course, please login or register now
|
|
|
|
|
